This article was written by Follow Monte Independent Investment Research: Michael Del Monte is a buy-side equity analyst with over 5 years of industry...
Reason for the update: New clinical data readout The most recent clinical data from NewAmsterdam Pharma (NASDAQ:NAMS) has showcased the potential of obicetrapib in...
When Carnival Corporation & plc (NYSE:CCL) Q3 2023 earnings hit late last week, the results broke a fourteen-month string of consecutive quarterly losses. To...
Minnesota and Washington are the states that provide the best services and supports for frail older adults, younger people with disabilities, and their families,...
Otis (NYSE:OTIS) emerged as a prominent elevator and escalator manufacturer following its spinoff from United Technologies in 2020. The company’s primary revenue stream comes...